Mevis Medical Solutions Stock Working Capital
M3V Stock | 24.00 0.40 1.64% |
MeVis Medical Solutions fundamentals help investors to digest information that contributes to MeVis Medical's financial success or failures. It also enables traders to predict the movement of MeVis Stock. The fundamental analysis module provides a way to measure MeVis Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MeVis Medical stock.
MeVis |
MeVis Medical Solutions Company Working Capital Analysis
MeVis Medical's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Competition |
Based on the company's disclosures, MeVis Medical Solutions has a Working Capital of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Working Capital (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
All Next | Launch Module |
MeVis Fundamentals
Current Valuation | 57.93 M | |||
Price To Book | 3.43 X | |||
Price To Sales | 3.67 X | |||
Market Capitalization | 58.97 M | |||
Total Asset | 31.2 M | |||
Annual Yield | 0.03 % | |||
Net Asset | 31.2 M |
About MeVis Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MeVis Medical Solutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MeVis Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MeVis Medical Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MeVis Stock Analysis
When running MeVis Medical's price analysis, check to measure MeVis Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MeVis Medical is operating at the current time. Most of MeVis Medical's value examination focuses on studying past and present price action to predict the probability of MeVis Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MeVis Medical's price. Additionally, you may evaluate how the addition of MeVis Medical to your portfolios can decrease your overall portfolio volatility.